N@N

ANGIODYNAMICS INC (NASDAQ:ANGO), Down By 5.34% ($0.71) From $13.290 After BUYINS.NET Report Predicted Stock Would Go Down Due T

^{Published on 2012-03-02 09:41:32 - WOPRAI}
 

March 2, 2012 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Monday, February 27th 2012 stating that ANGIODYNAMICS INC (NASDAQ:ANGO) was expected to go Down due to the Bearish conditions presented in the following report. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=ango&id=247252

At the time this story was written, ANGIODYNAMICS INC (NASDAQ:ANGO) is Down By $0.71 (5.34%) since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following specific fundamental or technical events may follow a predictable pattern. Many companies stock price histories show random or unpredictable movements around certain events. But some seem to repeat the same pattern quarter after quarter, year after year. We use powerful computers to uncover those events and correlations to generate predictions with high probabilities of generating very specific returns within very specific time periods.

The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

ANGIODYNAMICS INC (NASDAQ:ANGO) - AngioDynamics, Inc. designs, develops, manufactures, and markets various therapeutic and diagnostic devices that enable interventional physicians to treat peripheral vascular disease, tumors, and other non-coronary diseases. It operates in three segments: Peripheral Vascular, Access, and Oncology/Surgery. The Peripheral Vascular segment offers and manages venous, angiographic, percutaneous transluminal angioplasty (PTA), drainage, thrombolytic, targeted renal therapy, micro access, and transjugular access product lines. Its venous products include VenaCure and Sotradecol products; angiographic product line comprises angiographic catheters, entry needles, guidewires, and fluid management products; PTA product line consists of PTA dilation balloon catheters, including WORKHORSE and PROFILER to open blocked blood vessels and dialysis access sites; drainage product line includes TOTAL ABSCESSION general drainage catheters; and thrombolytic product line comprises PULSE SPRAY, UNI FUSE, and SPEEDLYSER catheters. The Access segment provides and manages dialysis, port, and PICC product lines. Its dialysis product line includes dialysis catheters, which are marketed under the DuraMax, SCHON, EVENMORE, DURA-FLOW, SCHON XL, and LIFEJET F-16 brands. The Oncology/Surgery segment offers radio frequency ablation products, which include radiofrequency ablation (RFA) disposable electrodes, RF resection device, and RFA generators; embolization products; and NanoKnife products, based on the principles of Irreversible Electroporation. The company offers its products to interventional radiologists, vascular surgeons, and surgical oncologists through a direct sales force in the United States and through a combination of direct sales and distributor relationships internationally. AngioDynamics, Inc. was founded in 1988 and is headquartered in Queensbury, New York.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor market-maker surveillance system tracking Level II market-makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 30 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies specifically for this report, but may have been compensated up to $1,200 per month in the past for unrelated data or report services. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net